Latest Articles

  • A nodule on a woman’s face
    Salvador Arias-Santiago, MD, José Aneiros-Fernández, MD, Antonio Cutando, PhD, Agustín Buendía-Eisman, PhD, Ramón Naranjo-Sintes, PhD, Antonio Campos, PhD and Miguel Alaminos-Mingorance
    Cleveland Clinic Journal of Medicine April 2012, 79 (4) 282-284; DOI: https://doi.org/10.3949/ccjm.79a.10115

    It is firm, pink, 10 mm in diameter, with surrounding telangiectasias. What is it?

  • Nonallergic rhinitis: Common problem, chronic symptoms
    Brian Schroer, MD and Lily C. Pien, MD
    Cleveland Clinic Journal of Medicine April 2012, 79 (4) 285-293; DOI: https://doi.org/10.3949/ccjm.79a11099

    Allergic and nonallergic rhinitis have similar symptoms, but their mechanisms and treatment differ.

  • Antireflux surgery in the proton pump inhibitor era
    Antireflux surgery in the proton pump inhibitor era
    William J. Bulsiewicz, MD, MSc and Ryan D. Madanick, MD
    Cleveland Clinic Journal of Medicine April 2012, 79 (4) 273-281; DOI: https://doi.org/10.3949/ccjm.79a.11097

    Although drug therapy with a proton pump inhibitor is the first-line treatment for gastro-esophageal reflux disease, surgery still has several specific indications.

  • High creatinine 6 months after renal transplant
    Neeraj Singh, MBBS and Anil K. Agarwal, MD
    Cleveland Clinic Journal of Medicine March 2012, 79 (3) 174-175; DOI: https://doi.org/10.3949/ccjm.79a.11050

    Ultrasonography showed a large fluid collection compressing the transplanted kidney. What is the diagnosis?

  • Update on contraceptive options: A case-based discussion
    Kristi Tough, MD and Holly L. Thacker, MD
    Cleveland Clinic Journal of Medicine March 2012, 79 (3) 207-212; DOI: https://doi.org/10.3949/ccjm.79a.11088

    Contraceptive counseling is both an art and a science. Here, the authors present several common scenarios.

  • Protease inhibitors: Silver bullets for chronic hepatitis C infection?
    Protease inhibitors: Silver bullets for chronic hepatitis C infection?
    Naim Alkhouri, MD and Nizar N. Zein, MD
    Cleveland Clinic Journal of Medicine March 2012, 79 (3) 213-222; DOI: https://doi.org/10.3949/ccjm.79a.11082

    These new drugs are a major step forward, and multidrug regimens that include them are the new standard of care.

  • Correction
    Cleveland Clinic Journal of Medicine March 2012, 79 (3) 222;
  • Reviewers 2011
    Cleveland Clinic Journal of Medicine March 2012, 79 (3) 192;
  • Cervical cancer screening (November 2011)
    David L. Keller, MD
    Cleveland Clinic Journal of Medicine March 2012, 79 (3) 164; DOI: https://doi.org/10.3949/ccjm.79c:03001

    Readers comment on the oral anticoagulant dabigatran (October 2011), and screening for cervical cancer (November 2011).

  • Exploring the human genome, and relearning genetics by necessity
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine March 2012, 79 (3) 162; DOI: https://doi.org/10.3949/ccjm.79b.12003

    The field of medical genetics continues to advance far beyond what many of us were exposed to in medical school.

Pages